Upgrade to SI Premium - Free Trial

Novocure (NVCR)

16.01 +0.50 (3.22%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/22/26)

Latest Headlines

NovoCure reports data breach affecting over 1,400 patient records September 1, 2026 7:03 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Wedbush July 24, 2026 7:47 AM - StreetInsider NovoCure Ltd. (NVCR) PT Lowered to $32 at H.C. Wainwright July 24, 2026 7:31 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Wells Fargo July 24, 2026 6:29 AM - StreetInsider Form 144 NovoCure Ltd Filed by: Leupin Nicolas July 23, 2026 4:22 PM - SEC Filing Novocure (NVCR) Tops Q2 EPS by 20c; offers guidance July 23, 2026 7:02 AM - StreetInsider Form 8-K NovoCure Ltd For: Jul 23 July 23, 2026 7:00 AM - SEC Filing Novocure Reports Second Quarter 2026 Financial Results July 23, 2026 7:00 AM - BizWire Form 10-Q NovoCure Ltd For: Jun 30 July 23, 2026 7:00 AM - SEC Filing JPMorgan Resumes NovoCure Ltd. (NVCR) at Neutral July 13, 2026 3:15 AM - StreetInsider Form 4 NovoCure Ltd For: Jun 30 Filed by: Puri Michal Nath July 1, 2026 4:34 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Leonard Frank X July 1, 2026 4:32 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Ben Arye Barak July 1, 2026 4:31 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Danziger Asaf July 1, 2026 4:30 PM - SEC Filing Novocure to Report Second Quarter 2026 Financial Results July 1, 2026 7:00 AM - BizWire Form 8-K NovoCure Ltd For: Jun 30 June 30, 2026 7:01 AM - SEC Filing Novocure's Optune Pax wins CE Mark for pancreatic cancer June 30, 2026 7:00 AM - StreetInsider Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer June 30, 2026 7:00 AM - BizWire FreeCast surges premarket; Accenture, Novocure slide June 18, 2026 8:02 AM - StreetInsider Novocure's TRIDENT trial misses primary endpoint in glioblastoma June 18, 2026 7:00 AM - StreetInsider Form 8-K NovoCure Ltd For: Jun 18 June 18, 2026 7:00 AM - SEC Filing Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma June 18, 2026 7:00 AM - BizWire Full Article List